Show simple item record

 
dc.contributorDepartament de Salut
dc.contributor.authorPérez-Troncoso, Daniel
dc.contributor.authorVelasco-Regulez, Borja
dc.contributor.authorRuiz-Baena, Jessica
dc.contributor.authorVivanco-Hidalgo, Rosa Maria
dc.contributor.authorChillarón, Juan J
dc.contributor.authorCliment, Elisenda
dc.contributor.authorBallesta, Silvia
dc.contributor.authorLlaurado, Gemma
dc.date.accessioned2023-06-12T11:49:06Z
dc.date.available2023-06-12T11:49:06Z
dc.date.issued2023-03
dc.identifier.citationPérez Troncoso D, Velasco Regúlez B, Ruiz Baena J, Vivanco Hidalgo RM, Chillarón Jordán JJ, Climent Biescas E, et al. La incidència de diabetis mellitus de tipus 1 durant la pandèmia de COVID-19 a Catalunya. Barcelona: Agència de Qualitat i Avaluació Sanitàries de Catalunya; 2023.
dc.identifier.urihttps://hdl.handle.net/11351/9723
dc.descriptionCoronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Type 1 diabetes mellitus; Chronic disease
dc.description.abstractIntroduction: Type 1 diabetes (T1D) is a chronic disease characterized by insufficient insulin production by the pancreas, leading to high blood glucose levels. Some countries have reported an increase in the incidence of T1D during the COVID-19 pandemic. Objective: To examine whether the incidence of T1D has increased during the COVID-19 pandemic in Catalonia. Methods: We estimated the expected incidence of T1D for 2020-2021 using a Poisson regression model based on historical data from 2010 to 2019. We compared the expected incidence with the observed incidence obtained from the population-based T1D registry of the PADRIS data analysis program of AQuAS. Results: In 2020, there was no significant increase in incidence compared to 2019, but in 2021 there was a significant increase of 28%. The largest increases occurred among people under 18 years old and women. Conclusions and discussion: There was a notable and statistically significant increase in T1D cases in Catalonia during the COVID-19 pandemic, although a causal relationship between the pandemic and diabetes cannot be established. Further studies are needed to explore the possible biological or social mechanisms that could explain this phenomenon and its clinical and health implications.
dc.language.isocat
dc.publisherAgència de Qualitat i Avaluació Sanitàries de Catalunya
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectCOVID-19 (Malaltia)
dc.subjectDiabetis - Epidemiologia - Catalunya
dc.subjectMalalties cròniques
dc.subject.meshCoronavirus Infections
dc.subject.meshDiabetes Mellitus, Type 1
dc.subject.mesh/epidemiology
dc.subject.meshCatalonia
dc.titleLa incidència de diabetis mellitus de tipus 1 durant la pandèmia de COVID-19 a Catalunya
dc.typeinfo:eu-repo/semantics/report
dc.subject.decsinfecciones por Coronavirus
dc.subject.decsdiabetes mellitus tipo I
dc.subject.decs/epidemiología
dc.subject.decsCataluña
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.authoraffiliation[Pérez Troncoso D, Ruiz Baena J, Vivanco Hidalgo RM] Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQUAS), Departament de Salut, Generalitat de Catalunya, Barcelona, Spain. [Chillarón Jordán JJ, Climent Biescas E, Ballesta Purroy S] Servei d’Endocrinologia i Nutrició, Hospital del Mar, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Barcelona, Spain. [Llauradó Cabot G] Servei d’Endocrinologia i Nutrició, Hospital del Mar, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Barcelona, Spain. Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asocia-das (CIBERDem), Instituto de Salud Carlos III, Madrid, Spain
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record